Welcome to our dedicated page for Semler Scientific news (Ticker: SMLR), a resource for investors and traders seeking the latest updates and insights on Semler Scientific stock.
Semler Scientific, Inc. (Nasdaq: SMLR) is an innovative medical risk-assessment company focused on developing, manufacturing, and marketing diagnostic and testing products that enhance patient care while bridging the gap between the cost of care and its compensation. Listed on Nasdaq since February 26, 2014, Semler operates primarily in the United States, offering proprietary technology solutions that improve clinical effectiveness and efficiency for healthcare providers, insurance plans, and risk assessment groups.
Semler's flagship product, QuantaFlo®, is a rapid, in-office test for measuring arterial blood flow in the extremities. This four-minute test aids in diagnosing peripheral arterial disease (PAD) and heart dysfunction (HD). QuantaFlo® is FDA-cleared and is employed by healthcare providers to evaluate patients' risks of mortality and major adverse cardiovascular events (MACE).
Beyond QuantaFlo®, Semler Scientific has made strategic alliances and investments to expand its product portfolio. The company has an exclusive marketing and distribution agreement with Mellitus Health, Inc. for Insulin Insights™, an FDA-cleared software product that recommends optimal insulin dosing for diabetic patients. Additionally, Semler holds minority investments in Mellitus, Monarch Medical Technologies LLC (developer of EndoTool® for inpatient glycemic management), and SYNAPS Dx.
In the latest financial results for Q3 2023, Semler reported consistent growth in quarterly revenue and pre-tax net income, predominantly from QuantaFlo® sales. The company continues to focus on expanding its business into heart dysfunction diagnosis.
Semler has also recently adopted Bitcoin as its primary treasury reserve asset, reflecting a strategic move to leverage the digital currency for long-term value and as a hedge against inflation. As of June 6, 2024, the company holds 828 bitcoins, underscoring its commitment to this innovative investment strategy.
More detailed information about Semler Scientific, its products, and investment strategies can be found on their website.
Semler Scientific (NASDAQ: SMLR) has announced the pricing of $85.0 million in 4.25% convertible senior notes due 2030, an increase from the previously announced $75.0 million. The notes, offered to qualified institutional buyers, will mature on August 1, 2030, with semiannual interest payments beginning August 1, 2025.
The initial conversion rate is 13.0826 shares per $1,000 principal amount, equivalent to approximately $76.44 per share, representing a 25% premium over the last reported stock price. The company expects net proceeds of approximately $81.4 million, with $6.6 million allocated to capped call transactions and the remainder for general corporate purposes, including bitcoin acquisition.
The company has implemented capped call transactions with a cap price of $107.01, representing a 75% premium over the current stock price, to offset potential dilution from note conversions.
Semler Scientific (SMLR) released preliminary unaudited Q4 2024 financial results, highlighting revenues between $12.1-12.5 million and operating income of $3.4-3.7 million. The company reported a significant unrealized gain of approximately $28.9 million from changes in bitcoin holdings' fair value.
As of January 17, 2025, Semler holds 2,321 bitcoins, acquired for $191.9 million at an average price of $82,689 per bitcoin, including fees. The company's cash, restricted cash, and cash equivalents stood at approximately $9.0 million as of December 31, 2024.
Complete Q4 and full-year 2024 financial results will be announced after market close on February 18, 2025, followed by a conference call with management.
Semler Scientific (NASDAQ: SMLR) has announced plans to offer $75.0 million in convertible senior notes due 2030 through a private offering to qualified institutional buyers. The company will grant initial purchasers an option for an additional $15.0 million in notes within a 13-day period.
The notes will be senior unsecured obligations with semiannual interest payments. Upon conversion, Semler can choose to pay in cash, common stock shares, or a combination thereof. The company plans to use the proceeds to fund capped call transactions and for general corporate purposes, including bitcoin acquisition.
The capped call transactions are designed to offset potential dilution from note conversion. The offering's completion depends on market conditions, with specific terms including interest rate and conversion rate to be determined at pricing.
Semler Scientific (NASDAQ: SMLR) has reported significant bitcoin acquisition activity between December 16, 2024, and January 10, 2025, purchasing 237 bitcoins for $23.3 million at an average price of $98,267 per bitcoin. The company's total bitcoin holdings now stand at 2,321 BTC, acquired for $191.9 million at an average price of $82,687 per bitcoin.
The company has expanded its ATM offering with Cantor Fitzgerald, increasing the total amount to $150 million, of which $121.8 million has been generated in gross proceeds. Semler's BTC Yield, a key performance indicator measuring the ratio between bitcoin holdings and assumed diluted shares, reached 72.6% from October to January and 99.3% since July 2024.
The company's basic shares outstanding increased from 6,988,000 in June 2024 to 9,597,000 in January 2025, with assumed diluted shares rising from 8,086,000 to 10,738,000 during the same period.
Semler Scientific (NASDAQ: SMLR) has expanded its bitcoin holdings by acquiring 211 BTC for $21.5 million between December 5-15, 2024, at an average price of $101,890 per bitcoin. The company now holds 2,084 BTC, purchased for $168.6 million at an average price of $80,916 per bitcoin.
The company has filed to increase its ATM offering by $50 million to $150 million total, having already generated $100 million in gross proceeds. Semler's BTC Yield, a key performance indicator measuring bitcoin holdings relative to diluted shares, reached 67.0% from October to December 2024 and 92.8% from July to December 2024.
Semler Scientific (SMLR) announced significant updates to its bitcoin (BTC) holdings and capital markets activity. Between November 25-December 4, 2024, the company acquired 303 bitcoins for $29.3 million at an average price of $96,779 per bitcoin. As of December 4, 2024, SMLR holds 1,873 bitcoins, acquired for $147.1 million at an average of $78,553 per bitcoin.
The company expanded its ATM offering with Cantor Fitzgerald by an additional $50 million, bringing the total to $100 million, of which $79.8 million has been generated. SMLR reported a BTC Yield of 54.7% from October-December 2024 and 78.7% from July-December 2024. The company's basic shares outstanding increased to 8,813,000 as of December 4, 2024.
Semler Scientific (NASDAQ: SMLR) announced significant updates to its bitcoin holdings and capital market activities. The company purchased 297 additional bitcoins for $29.1 million between November 18-22, 2024, at an average price of $97,995 per bitcoin. Their total bitcoin holdings now stand at 1,570 BTC, acquired for $117.8 million at an average price of $75,039 per bitcoin.
The company also launched an additional $50.0 million ATM offering, increasing the total ATM offering to $100.0 million. Semler reported a BTC Yield of 37.1% from October to November 2024, and 58.4% since implementing its bitcoin treasury strategy in July 2024.
Semler Scientific (SMLR) announced significant bitcoin activity and capital market updates. Between November 6-15, 2024, the company acquired 215 bitcoins for $17.7 million at an average price of $82,502 per bitcoin. Their total holdings now stand at 1,273 bitcoins, purchased at an aggregate price of $88.7 million.
Through their ATM offering agreement with Cantor Fitzgerald, Semler raised $21.5 million by selling 505,544 shares. The company reported a BTC Yield of 18.9% from October to November 2024, and 37.3% since implementing their bitcoin treasury strategy in July 2024.
Semler Scientific (NASDAQ: SMLR) reported Q3 2024 financial results showing revenues of $13.5M, down 17% year-over-year, and net income of $5.6M ($0.80 per basic share). The company announced additional bitcoin purchases, bringing total holdings to 1,058 bitcoins acquired for $71.0M. Income from operations was $5.1M, a 20% decrease from Q3 2023. The company's two largest customers comprised 44% and 29% of Q3 2024 revenues. Semler continues to focus on bitcoin acquisition while maintaining its healthcare business, utilizing both operating cash flow and ATM program proceeds for purchases.
Semler Scientific (Nasdaq: SMLR) has announced it will report financial results for the third quarter and nine months ended September 30, 2024, and provide an update on its Bitcoin holdings after the close of U.S. financial markets on Monday, November 4, 2024. The company will host a conference call at 4:30 pm ET the same day, led by CEO Doug Murphy-Chutorian, along with Chairman Eric Semler, CFO Renae Cormier, and COO Jennifer Oliva-Herrington.
Participants are encouraged to pre-register for the call using the provided link. Those unable to pre-register can dial in using the domestic (833-816-1161) or international (412-317-0617) numbers. Questions can be submitted prior to the call via email to ir@semlerscientific.com. The conference call will be archived on Semler Scientific's website.
FAQ
What is the current stock price of Semler Scientific (SMLR)?
What is the market cap of Semler Scientific (SMLR)?
What does Semler Scientific, Inc. do?
What is QuantaFlo®?
When did Semler Scientific go public?
What recent achievements has Semler Scientific made?
What is Insulin Insights™?
How is Semler Scientific involved with Bitcoin?
Who are Semler Scientific’s primary customers?
Where is Semler Scientific headquartered?
What other companies is Semler Scientific invested in?
What is the financial outlook for Semler Scientific?
